| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) S Miyakis, MD Lockshin, T Atsumi, DW Branch, RL Brey, R Cervera, ... Journal of thrombosis and haemostasis 4 (2), 295-306, 2006 | 8668 | 2006 |
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients R Cervera, JC Piette, J Font, MA Khamashta, Y Shoenfeld, MT Camps, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 2652 | 2002 |
| 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ... Annals of the rheumatic diseases 78 (6), 736-745, 2019 | 1999 | 2019 |
| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ... Annals of the rheumatic diseases 74 (6), 1011-1018, 2015 | 1171* | 2015 |
| The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation CG Skorpen, M Hoeltzenbein, A Tincani, R Fischer-Betz, E Elefant, ... Annals of the rheumatic diseases 75 (5), 795-810, 2016 | 1156 | 2016 |
| EULAR recommendations for the management of antiphospholipid syndrome in adults MG Tektonidou, L Andreoli, M Limper, Z Amoura, R Cervera, ... Annals of the rheumatic diseases 78 (10), 1296-1304, 2019 | 1075 | 2019 |
| EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including … GK Bertsias, JPA Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, ... Annals of the rheumatic diseases 67 (2), 195-205, 2008 | 1055 | 2008 |
| EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and … L Andreoli, GK Bertsias, N Agmon-Levin, S Brown, R Cervera, ... Annals of the rheumatic diseases 76 (3), 476-485, 2017 | 918 | 2017 |
| EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for … GK Bertsias, JPA Ioannidis, M Aringer, E Bollen, S Bombardieri, IN Bruce, ... Annals of the rheumatic diseases 69 (12), 2074-2082, 2010 | 913 | 2010 |
| Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome V Pengo, G Denas, G Zoppellaro, SP Jose, A Hoxha, A Ruffatti, L Andreoli, ... Blood, The Journal of the American Society of Hematology 132 (13), 1365-1371, 2018 | 812 | 2018 |
| Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice JC Souberbielle, JJ Body, JM Lappe, M Plebani, Y Shoenfeld, TJ Wang, ... Autoimmunity reviews 9 (11), 709-715, 2010 | 792 | 2010 |
| International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies N Agmon-Levin, J Damoiseaux, C Kallenberg, U Sack, T Witte, M Herold, ... Annals of the rheumatic diseases 73 (1), 17-23, 2014 | 727 | 2014 |
| Anti-inflammatory and immunosuppressive drugs and reproduction M Østensen, M Khamashta, M Lockshin, A Parke, A Brucato, H Carp, ... Arthritis research & therapy 8, 1-19, 2006 | 696 | 2006 |
| Risk of congenital complete heart block in newborns of mothers with anti‐Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women A Brucato, M Frassi, F Franceschini, R Cimaz, D Faden, MP Pisoni, ... Arthritis & Rheumatism 44 (8), 1832-1835, 2001 | 631 | 2001 |
| Covid-19 and autoimmunity M Ehrenfeld, A Tincani, L Andreoli, M Cattalini, A Greenbaum, D Kanduc, ... Autoimmunity reviews 19 (8), 102597, 2020 | 605 | 2020 |
| European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies M Mosca, C Tani, M Aringer, S Bombardieri, D Boumpas, R Brey, ... Annals of the rheumatic diseases 69 (7), 1269-1274, 2010 | 516 | 2010 |
| Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β2‐glycoprotein I N Di Simone, PL Meroni, N Del Papa, E Raschi, D Caliandro, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 427 | 2000 |
| A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS) R Van Vollenhoven, A Voskuyl, G Bertsias, C Aranow, M Aringer, ... Annals of the rheumatic diseases 76 (3), 554-561, 2017 | 403 | 2017 |
| Endothelial cells as target for antiphospholipid antibodies. Human Polyclonal and Monoclonal Anti‐β2‐Glycoprotein I Antibodies React In Vitro with Endothelial Cells Through … ND Papa, L Guidali, A Sala, C Buccellati, MA Khamashta, K Ichikawa, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1997 | 373 | 1997 |
| The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome O Amengual, T Atsumi, MA Khamashta, GRV Hughes Thrombosis and haemostasis 79 (02), 276-281, 1998 | 349 | 1998 |
